The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Open accessAbstract
PURPOSE: The accurate interpretation of variation in Mendelian disease genes has lagged behind data generation as sequencing has become increasingly accessible. Ongoing large sequencing efforts present huge interpretive challenges, but they also provide an invaluable opportunity to characterize the spectrum and importance of rare variation. METHODS: We analyzed sequence data from 7,855 clinical cardiomyopathy cases and 60,706 Exome Aggregation Consortium (ExAC) reference samples to obtain a better understanding of genetic variation in a representative autosomal dominant disorder. RESULTS: We found that in some genes previously reported as important causes of a given cardiomyopathy, rare variation is not clinically informative because there is an unacceptably high likelihood of false-positive interpretation. By contrast, in other genes, we find that diagnostic laboratories may be overly conservative when assessing variant pathogenicity. CONCLUSIONS: We outline improved analytical approaches that evaluate which genes and variant classes are interpretable and propose that these will increase the clinical utility of testing across a range of Mendelian diseases.Genet Med 19 2, 192-203.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Self-citationA map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citationACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T. T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,275
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Self-citationAckerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.020 · Cited by 1,479
Self-citationNew Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.019 · Cited by 1,384
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,279
Atlas of the clinical genetics of human dilated cardiomyopathy
Haas, J., Frese, K. S., Peil, B., Kloos, W., Keller, A., Nietsch, R., Feng, Z., Müller, S., Kayvanpour, E., Vogel, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu301 · Cited by 557
Bezzina, C. R., Barc, J., Mizusawa, Y., Remme, C. A., Gourraud, J.-B., Simonet, F., Verkerk, A. O., Schwartz, P. J., Crotti, L., Dagradi, F., et al. (2013) · Nature Genetics · doi:10.1038/ng.2712 · Cited by 542
Watkins, H., Ashrafian, H., & Redwood, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0902923 · Cited by 496
Self-citationRoberts, A. M., Ware, J. S., Herman, D. S., Schafer, S., Baksi, J., Bick, A. G., Buchan, R. J., Walsh, R., John, S., Wilkinson, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010134 · Cited by 491
Self-citationGenetic mutations and mechanisms in dilated cardiomyopathy
McNally, E. M., Golbus, J. R., & Puckelwartz, M. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62862 · Cited by 478
CONCEPTUAL PROBLEMS IN THE DEFINITION AND INTERPRETATION OF ATTRIBUTABLE FRACTIONS
GREENLAND, S., & ROBINS, J. M. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115073 · Cited by 414
Alfares, A. A., Kelly, M. A., McDermott, G., Funke, B. H., Lebo, M. S., Baxter, S. B., Shen, J., McLaughlin, H. M., Clark, E. H., Babb, L. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.205 · Cited by 412
Self-citationThe landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing
Pugh, T. J., Kelly, M. A., Gowrisankar, S., Hynes, E., Seidman, M. A., Baxter, S. M., Bowser, M., Harrison, B., Aaron, D., Mahanta, L. M., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2013.204 · Cited by 363
Self-citationXue, Y., Ankala, A., Wilcox, W. R., & Hegde, M. R. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.122 · Cited by 349
Attributable risk percent in case-control studies.
Cole, P., & MacMahon, B. (1971) · Journal of Epidemiology & Community Health · doi:10.1136/jech.25.4.242 · Cited by 342
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy
Xu, T., Yang, Z., Vatta, M., Rampazzo, A., Beffagna, G., Pillichou, K., Scherer, S. E., Saffitz, J., Kravitz, J., Zareba, W., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.020 · Cited by 320
Update 2011: Clinical and Genetic Issues in Familial Dilated Cardiomyopathy
Hershberger, R. E., & Siegfried, J. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.015 · Cited by 319
Parks, S. B., Kushner, J. D., Nauman, D., Burgess, D., Ludwigsen, S., Peterson, A., Li, D., Jakobs, P., Litt, M., Porter, C. B., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.026 · Cited by 256
Hershberger, R. E., Norton, N., Morales, A., Li, D., Siegfried, J. D., & Gonzalez-Quintana, J. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.109.912345 · Cited by 237
Genetic advances in sarcomeric cardiomyopathies: state of the art
Ho, C. Y., Charron, P., Richard, P., Girolami, F., Van Spaendonck-Zwarts, K. Y., & Pinto, Y. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv025 · Cited by 234
Natural Selection on Genes that Underlie Human Disease Susceptibility
Blekhman, R., Man, O., Herrmann, L., Boyko, A. R., Indap, A., Kosiol, C., Bustamante, C. D., Teshima, K. M., & Przeworski, M. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.074 · Cited by 222
Andreasen, C., Nielsen, J. B., Refsgaard, L., Holst, A. G., Christensen, A. H., Andreasen, L., Sajadieh, A., Haunsø, S., Svendsen, J. H., & Olesen, M. S. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.283 · Cited by 214
Hariharan, R., Alberg, C., Sagoo Gurdeep, S., Hilary, B., Behr Elijah, R., 奚卉, & 杜昕 (2012) · doi:10.3760/cma.j.issn.1007-9742.2012.01.138 · Cited by 197
Hershberger, R. E., Parks, S. B., Kushner, J. D., Li, D., Ludwigsen, S., Jakobs, P., Nauman, D., Burgess, D., Partain, J., & Litt, M. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00017.x · Cited by 195
Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy
Osio, A., Tan, L., Chen, S. N., Lombardi, R., Nagueh, S. F., Shete, S., Roberts, R., Willerson, J. T., & Marian, A. J. (2007) · Circulation Research · doi:10.1161/01.res.0000263008.66799.aa · Cited by 192
Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy
Chiu, C., Bagnall, R. D., Ingles, J., Yeates, L., Kennerson, M., Donald, J. A., Jormakka, M., Lind, J. M., & Semsarian, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.016 · Cited by 191
Maron, B. J., Maron, M. S., & Semsarian, C. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.009 · Cited by 162
Lopes, L. R., Syrris, P., Guttmann, O. P., O'Mahony, C., Tang, H. C., Dalageorgou, C., Jenkins, S., Hubank, M., Monserrat, L., McKenna, W. J., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-306387 · Cited by 162
Targeted next-generation sequencing: A novel diagnostic tool for primary immunodeficiencies
Nijman, I. J., van Montfrans, J. M., Hoogstraat, M., Boes, M. L., van de Corput, L., Renner, E. D., van Zon, P. H. A., van Lieshout, S., Elferink, M., van der Burg, M., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.032 · Cited by 160
Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy
Arimura, T., Bos, J. M., Sato, A., Kubo, T., Okamoto, H., Nishi, H., Harada, H., Koga, Y., Moulik, M., Doi, Y. L., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.082 · Cited by 159
First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy
Hoffmann, B., Schmidt-Traub, H., Perrot, A., Osterziel, K. J., & Gessner, R. V. (2001) · Human Mutation · doi:10.1002/humu.1143 · Cited by 151
Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy
Ingles, J., Sarina, T., Yeates, L., Hunt, L., Macciocca, I., McCormack, L., Winship, I., McGaughran, J. M., Atherton, J. J., & Semsarian, C. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.44 · Cited by 137
Robinson, P. J., Mirza, M., Knott, A., Abdulrazzak, H., Willott, R. H., Marston, S. B., Watkins, H. C., & Redwood, C. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203446200 · Cited by 130
Self-citationEstimability and estimation of excess and etiologic fractions
Robins, J. M., & Greenland, S. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080709 · Cited by 117
How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
Marston, S. B., Copeland, O., Gehmlich, K., Schlossarek, S., & Carrrier, L. (2011) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-011-9268-3 · Cited by 112
Statistical method on nonrandom clustering with application to somatic mutations in cancer
Ye, J., Pavlı́ček, A., Lunney, E. A., Rejto, P. A., & Teng, C.-H. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-11 · Cited by 73
Targeted Analysis of Whole Genome Sequence Data to Diagnose Genetic Cardiomyopathy
Golbus, J. R., Puckelwartz, M. J., Dellefave‐Castillo, L. M., Fahrenbach, J. P., Nelakuditi, V., Pesce, L. L., Pytel, P., & McNally, E. M. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000578 · Cited by 69
Wooderchak‐Donahue, W. L., Vansant-Webb, C. H., Tvrdik, T., Plant, P., Lewis, T. B., Stocks, J., Raney, J. A., Meyers, L., Berg, A. E., Rope, A. F., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37085 · Cited by 68
Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise
Kapplinger, J. D., Landstrom, A. P., Bos, J. M., Salisbury, B. A., Callis, T. E., & Ackerman, M. J. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9542-z · Cited by 53
Turner, T. N., Douville, C. B., Kim, D., Stenson, P. D., Cooper, D. N., Chakravarti, A., & Karchin, R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv309 · Cited by 49
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Metadata
- Authors
- Walsh, R., Thomson, K. L., Ware, J. S., Funke, B. H., Woodley, J., McGuire, K. J., Mazzarotto, F., Blair, E., Seller, A., Taylor, J. C., Minikel, E. V., Exome Aggregation Consortium, MacArthur, D. G., Farrall, M., Cook, S. A., & Watkins, H.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 19
- Issue
- 2
- Pages
- 192-203
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2517515998
- Cited by
- 734
- References
- 46
- FWCI
- 61.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.